Author: Sean Williams, The Motley Fool

Short-term uncertainty has led to a golden opportunity for long-term investors.

These companies possess the right blend of competitive advantages and catalysts to make their patient shareholders notably richer.

A valuation tool with 154 years of historical data in its sails sets the record straight.

The Oracle of Omaha is a big believer in concentrating Berkshire’s invested assets into his top ideas.

These companies have the necessary catalysts to make their patient investors notably richer.